4.3 Review

Prolactin-secreting tumors: what's new?

Journal

EXPERT REVIEW OF ANTICANCER THERAPY
Volume 6, Issue 9, Pages S29-S35

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1586/14737140.6.9s.S29

Keywords

bromocriptine; cabergoline; pituitary tumor; prolactin; prolactinoma

Categories

Ask authors/readers for more resources

Prolactinomas are a common cause of reproductive/sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history and physical examination, routine chemistries, a pregnancy test and a thyroid-stimulating hormone, imaging with magnetic resonance imaging or computed tomography will delineate the size and extent of the tumor. Medical therapy with cabergoline or bromocriptine is the initial treatment of choice. When infertility is the primary indication for treatment, bromocriptine use has an extensive safety experience and is preferred by some clinicians. However, for other indications, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective or not tolerated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available